Demethylation of E-cadherin gene in nasopharyngeal carcinoma could serve as a potential therapeutic strategy

Journal of Biochemistry

Volumn 149, Issue 1, 2011, Pages 49-54

  Ran, Yonggang ^a   Wu, Shouzhen ^b   You, Yanjie ^c,d  

^a Bethune Military Medical College   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^d SHANTOU UNIVERSITY   (China)

Author keywords

bisulphate sequencing; demethylation; E cadherin; nasopharyngeal carcinoma

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; UVOMORULIN;

ARTICLE; BLOOD; CONTROLLED STUDY; DEMETHYLATION; DOWN REGULATION; GENE; HUMAN; HUMAN CELL; NASOPHARYNX CARCINOMA; PROMOTER REGION; PROTEIN EXPRESSION;

AZACITIDINE; CADHERINS; CPG ISLANDS; DNA MODIFICATION METHYLASES; DOWN-REGULATION; HUMANS; METHYLATION; NASOPHARYNGEAL NEOPLASMS; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 78650657110     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvq128     Document Type: Article

References (25)

1. Berx, G., Staes, K., van Hengel, J., Molemans, F., Bussemakers, M.J., van Bokhoven, A., and van Roy, F. (1995) Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1). Genomics 26, 281-289
2. Zheng, Z., Pan, J., Chu, B., Wong, Y.C., Cheung, A.L., and Tsao, S.W. (1999) Downregulation and abnormal expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis. Hum. Pathol. 30, 458-466
3. Thiery, J.P. (2002) Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer. 2, 442-454
4. Fujita, N., Jaye, D.L., Kajita, M., Geigerman, C, Moreno, C.S., and Wade, P.A. (2003) MTA3, a Mi-2/ NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 113, 207-219
5. Yang, J., Mani, S.A., Donaher, J.L., Ramaswamy, S., Itzykson, R.A., Come, C, Savagner, P., Gitelman, I., Richardson, A., and Weinberg, R.A. (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117, 7-939
6. Comijn, J., Berx, G., Vermassen, P., Verschueren, K., van Grunsven, L., Bruyneel, E., Mareel, M., Huylebroeck, D., and van Roy, F. (2001) The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol. Cell. 7, 1267-1278
7. Strathdee, G. (2002) Epigenetic versus genetic alterations in the inactivation of E-cadherin. Semin. Cancer Biol. 12, 373-379
8. Takeno, S., Noguchi, T., Fumoto, S., Kimura, Y., Shibata, T., and Kawahara, K. (2004) E-cadherin expression in patients with esophageal squamous cell carcinoma: promoter methylation, Snail overexpression, and clinicopathologic implications. Am. J. Clin. Pathol. 122, 78-84
9. Niemhom, S., Kitazawa, S., Kitazawa, R., Maeda, S., and Leopairat, J. (2008) Methylation of epithelial-cadherin gene promoter is associated with Epstein-Barr virus in nasopharyngeal carcinoma. Cancer Detect. Prev. 32, 127-134
10. Tsao, S.W., Liu, Y., Wang, X., Yuen, P.W., Leung, S.Y., Yuen, S.T., Pan, J., Nicholls, J.M., Cheung, A.L., and Wong, Y.C. (2003) The association of E-cadherin expression and the methylation status of the E-cadherin gene in nasopharyngeal carcinoma cells. Eur. J. Cancer. 39, 524-531 (Pubitemid 36173698)
11. Krishna, S.M., Kattoor, J., and Balaram, P. (2005) Down regulation of adhesion protein E-cadherin in Epstein-Barr virus infected nasopharyngeal carcinomas. Cancer Biomark 1, 271-277
12. Si, H.X., Tsao, S.W., Lam, K.Y., Srivastava, G., Liu, Y., Wong, Y.C, Shen, Z.Y., and Cheung, A.L. (2001) E-cadherin expression is commonly downregulated by CpG island methylation in esophageal carcinoma cells. Cancer Lett. 173, 71-78
13. Ho, JH. (1978) An epidemiologic and clinical study of nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 4, 182-198
14. Wells, A., Yates, C, and Shepard, C.R. (2008) E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. Clin. Exp. Metastasis 25, 621-628
15. Arai, M., Imazeki, F., Sakai, Y., Mikata, R., Tada, M., Seki, N., Shimada, H., Ochiai, T., and Yokosuka, O. (2008) Analysis of the methylation status of genes up-regulated by the demethylating agent, 5-aza-2'-deox- ycytidine, in esophageal squamous cell carcinoma. Oncol. Rep. 20, 405-412
16. Suzuki, H., Gabrielson, E., Chen, W., Anbazhagan, R., van Engeland, M., Weijenberg, M.P., Herman, J.G., and Baylin, S.B. (2002) A genomic screen for genes upregu-lated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat. Genet. 31, 141-149
17. Oki, Y., Jelinek, J., Shen, L., Kantarjian, H.M., and Issa, J.P. (2008) Induction of hypomethylation and molecular response after decitabine therapy in patients with chronic myelomonocytic leukemia. Blood 111, 2382-2384
18. Wang, G., Hu, X., Lu, C, Su, C, Luo, S., and Luo, Z.W. (2008) Promoter-methylation associated defective expression of E-cadherin in primary non-small cell lung cancer. Lung Cancer 62, 162-172
19. Nam, J.S., Ino, Y., Kanai, Y., Sakamoto, M., and Hirohashi, S. (2004) 5-aza-2'-deoxycytidine restores the E-cadherin system in E-cadherin-silenced cancer cells and reduces cancer metastasis. Clin. Exp. Metastasis 21, 49-56
20. Hurtubise, A. and Momparler, R.L. (2004) Evaluation of antineoplastic action of 5-aza-2'-deoxycytidine (Dacogen) and docetaxel (Taxotere) on human breast, lung and prostate carcinoma cell lines. Anticancer Drugs 15, 161-167
21. Belinsky, S.A., Palmisano, W.A., Gilliland, F.D., Crooks, L.A., Divine, K.K., Winters, S.A., Grimes, M.J., Harms, H.J., Tellez, C.S., Smith, T.M., Moots, P.P., Lechner, J.F., Stidley, C.A., and Crowell, R.E. (2002) Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res. 62, 2370-2377
22. Cairns, P., Esteller, M., Herman, J.G., Schoenberg, M., Jeronimo, C, Sanchez-Cespedes, M., Chow, N.H., Grasso, M., Wu, L., Westra, W.B., and Sidransky, D. (2001) Molecular detection of prostate cancer in urine by GSTP1 hypermethylation. Clin. Cancer Res. 7, 2727-2730
23. Hickey, K.P., Boyle, K.P., Jepps, H.M., Andrew, A.C., Buxton, E.J., and Burns, P.A. (1999) Molecular detection of tumour DNA in serum and peritoneal fluid from ovarian cancer patients. Br. J. Cancer 80, 1803-1808
24. Wang, J., Qin, Y., Li, B., Sun, Z., and Yang, B. (2006) Detection of aberrant promoter methylation of GSTP1 in the tumor and serum of Chinese human primary hepatocellular carcinoma patients. Clin. Biochem. 39, 344-348
25. Indovina, P., Acquaviva, A., De Falco, G., Rizzo, V., Onnis, A., Luzzi, A., Giorgi, F., Hadjistilianou, T., Toti, P., Tomei, V., Pentimalli, F., Carugi, A., and Giordano, A. (2010) Downregulation and aberrant promoter methylation of p16INK4A: a possible novel heritable susceptibility marker to retinoblastoma. J. Cell. Physiol. 223, 143-150